Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter

Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 as against Rs 130.41 crore during the previous quarter ended June 2023. Sales rose 16.64% to Rs 1815.14 crore in the quarter ended June 2024 as against Rs 1556.16 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	1815.14	1556.16	17
OPM %	18.53	19.00	-
PBDT	301.00	258.52	16
PBT	207.41	191.34	8
NP	144.08	130.41	10